Improving outcomes for R/R DLBCL with polatuzumab vedotin

Patients with relapsed, transplant ineligible diffuse large B-cell lymphoma (DLBCL) face extremely poor outcomes. In this video, recorded at the 23rd Congress of the European Hematology Association (E... Author: VJHemOnc Added: 08/07/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts